bullish
Cerecor's Novel Drugs for Major Depression. 'Failed' Trial or Buying Opportunity in the Stock?
337 Views01 Dec 2016 11:57
We listened to Cerecor Inc (CERC US) management's conference call (link) about the phase 2 results of CERC-301 as adjunct therapy in major...
SUMMARY
(Sign Up to Access)Get started on the Smartkarma Research Network with a complimentary Preview Pass to:
- Unlock all research summaries
- Follow top, independent analysts
- Receive personalised alerts and emails
- Access Briefings, Analytics, and Events
Upgrade anytime to our paid plans for full-length research, real-time analyst discussions, and more.
Join a thriving community of 45,000+ investors, including the top global asset managers managing over $13trn in assets.
or
Already have an account? Sign In Now
Full Insight
(Paid Plans Only, 3-minute read)
Discussions
(Paid Plans Only)
Price Chart(Sign Up to Access)
- Amicus Therapeutics: New Long Position. Another Contrarian Play with Upcoming Catalysts03 Dec 2016
- Actionable Idea: Medgenics: Upcoming Catalyst, Recent Insider Buying, Huge Potential Market in ADHD.02 Dec 2016
- Cerecor's Novel Drugs for Major Depression. 'Failed' Trial or Buying Opportunity in the Stock?01 Dec 2016
- Actionable Ideas in the Biotechnology and Pharmaceutical Sectors (Incl. Insider Buying): November 2829 Nov 2016
- Some Actionable Ideas in the Biotechnology and Pharmaceutical Sector: October 31 Sector Update01 Nov 2016
x